Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Wolfe Research Downgrades Edwards Lifesciences to Peer Perform

Wolfe Research analyst Mike Polark downgrades Edwards Lifesciences (NYSE:EW) from Outperform to Peer Perform.

byBenzinga Newsdesk

December 2, 2022

1 minute read

Wolfe Research analyst Mike Polark downgrades Edwards Lifesciences (NYSE:EW) from Outperform to Peer Perform.

SVB Leerink Maintains Outperform on ACADIA Pharmaceuticals, Lowers Price Target to $28

By Benzinga Newsdesk

Today, 2:53 AM

SVB Leerink analyst Marc Goodman maintains ACADIA Pharmaceuticals (NASDAQ:ACAD) with a Outperform and lowers the price target from $31 to $28.

ACAD

This Cryptocurrency Has Beaten Shiba Inu, Dogecoin And Ethereum Gains By Far Over Past Month And Still Looks Unstoppable

By Shivdeep Dhaliwal

Today, 2:53 AM

Loopring (CRYPTO: LRC) has shot up over 630% in the past 30 days, outpacing the gains of Shiba Inu (CRYPTO: SHIB), Dogecoin (CRYPTO: DOGE), and

$DOGE

Credit Suisse Maintains Outperform on Redwood Trust, Raises Price Target to $14

By vishwanath@benzinga.com

Today, 2:53 AM

Credit Suisse analyst Douglas Harter maintains Redwood Trust (NYSE:RWT) with a Outperform and raises the price target from $13 to $14.

RWT

Dynagas LNG Partners Q2 EPS $0.17, Inline, Sales $33.42M Beat $32.31M Estimate

By Benzinga Newsdesk

Today, 2:53 AM

Dynagas LNG Partners (NYSE:DLNG) reported quarterly earnings of $0.17 per share which met the analyst consensus estimate. This is a 15 percent decrease over earnings of $0.20 per share from the same period last year.

DLNG

Wolfe Research Downgrades Edwards Lifesciences to Peer Perform

Related Posts

SVB Leerink Maintains Outperform on ACADIA Pharmaceuticals, Lowers Price Target to $28

This Cryptocurrency Has Beaten Shiba Inu, Dogecoin And Ethereum Gains By Far Over Past Month And Still Looks Unstoppable

Credit Suisse Maintains Outperform on Redwood Trust, Raises Price Target to $14

Dynagas LNG Partners Q2 EPS $0.17, Inline, Sales $33.42M Beat $32.31M Estimate